Literature DB >> 14612151

Na+ and the substrate permeation pathway in dopamine transporters.

Nianhang Chen1, Maarten E A Reith.   

Abstract

Advances have been made in characterizing the relationship between Na+ and the substrate permeation pathway in the dopamine transporter. This review covers the role of Na+ in co-transport with dopamine as well as in the recognition of dopamine. Apparent recognition depends on the preparation studied: it differs between intact cells heterologously expressing the dopamine transporter and membranes prepared from these cells. In our search for amino acid residues in the transporter involved in Na+ action, W84 and D313 were found to play a special role in cation interaction, with evidence for regulation of both Na+ and H+ sensitivity. Mutation of D313 to N appeared to decrease the affinity for the dopamine transporter in intact cells, not by altering recognition per se. A model is proposed in which access of dopamine, not recognition itself, is regulated by D313 and Na+. Thus, the role of external Na+ in intact cell preparations is to turn dopamine transporters to the externally facing form, allowing access of dopamine to its binding site.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14612151     DOI: 10.1016/j.ejphar.2003.08.070

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

Review 1.  The Role of Intracellular Sodium in the Regulation of NMDA-Receptor-Mediated Channel Activity and Toxicity.

Authors:  Xian-Min Yu
Journal:  Mol Neurobiol       Date:  2006-02       Impact factor: 5.590

Review 2.  Recognition of psychostimulants, antidepressants, and other inhibitors of synaptic neurotransmitter uptake by the plasma membrane monoamine transporters.

Authors:  Christopher K Surratt; Okechukwu T Ukairo; Suneetha Ramanujapuram
Journal:  AAPS J       Date:  2005-10-27       Impact factor: 4.009

3.  Reconstructing a chloride-binding site in a bacterial neurotransmitter transporter homologue.

Authors:  Sotiria Tavoulari; Ahsan N Rizwan; Lucy R Forrest; Gary Rudnick
Journal:  J Biol Chem       Date:  2010-11-29       Impact factor: 5.157

4.  Dopamine transporter-dependent and -independent striatal binding of the benztropine analog JHW 007, a cocaine antagonist with low abuse liability.

Authors:  Theresa A Kopajtic; Yi Liu; Christopher K Surratt; David M Donovan; Amy H Newman; Jonathan L Katz
Journal:  J Pharmacol Exp Ther       Date:  2010-09-20       Impact factor: 4.030

5.  Mechanism for cocaine blocking the transport of dopamine: insights from molecular modeling and dynamics simulations.

Authors:  Xiaoqin Huang; Howard H Gu; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2009-11-12       Impact factor: 2.991

6.  Fluoxetine (Prozac) binding to serotonin transporter is modulated by chloride and conformational changes.

Authors:  Sotiria Tavoulari; Lucy R Forrest; Gary Rudnick
Journal:  J Neurosci       Date:  2009-07-29       Impact factor: 6.167

7.  How dopamine transporter interacts with dopamine: insights from molecular modeling and simulation.

Authors:  Xiaoqin Huang; Chang-Guo Zhan
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

8.  Importance of cholesterol in dopamine transporter function.

Authors:  Kymry T Jones; Juan Zhen; Maarten E A Reith
Journal:  J Neurochem       Date:  2012-10-11       Impact factor: 5.372

9.  Investigating the Mechanism of Sodium Binding to SERT Using Direct Simulations.

Authors:  Dániel Szöllősi; Thomas Stockner
Journal:  Front Cell Neurosci       Date:  2021-05-10       Impact factor: 5.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.